The effects of altered apolipoprotein A-I structure on plasma HDL concentration (Q34635650)

3 August 2017

1 reference

title

The effects of altered apolipoprotein A-I structure on plasma HDL concentration (English)

1 reference

3 August 2017

Mary G Sorci-Thomas

1

1 reference

PubMed ID

12007737

3 August 2017

Michael J Thomas

series ordinal

2

1 reference

3 August 2017

1 April 2002

1 reference

Trends in Cardiovascular Medicine

3 August 2017

1 reference

3 August 2017

12

1 reference

3 August 2017

121-128

1 reference

3 August 2017

3

1 reference

Extensive intimal apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

In vivo metabolism of proapolipoprotein A-I in Tangier disease

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Apolipoprotein genetic variation and human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Structural models of human apolipoprotein A-I: a critical analysis and review

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Role of the Arg123-Tyr166 paired helix of apolipoprotein A-I in lecithin:cholesterol acyltransferase activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

A novel mutant, ApoA-I nichinan (Glu235-->0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

HDL deficiency in genetically engineered mice requires elevated LDL to accelerate atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

The antiatherogenic role of high-density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Apolipoprotein A1 Baltimore (Arg10?Leu), a new ApoA1 variant

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Proteolytic degradation and impaired secretion of an apolipoprotein A-I mutant associated with dominantly inherited hypoalphalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Apolipoprotein A-IFin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Apolipoprotein A-I(Zavalla) (Leu159-->Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

A cysteine-containing truncated apo A-I variant associated with HDL deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Identification of two apolipoprotein variants, A-I Karatsu (Tyr 100-->His) and A-I Kurume (His 162-->Gln)

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Molecular basis of exchangeable apolipoprotein function

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-I(Zaragoza) (L144R).

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Targeted disruption of the mouse lecithin:cholesterol acyltransferase (LCAT) gene. Generation of a new animal model for human LCAT deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Structure and function of apolipoprotein A-I and high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Recombinant apolipoproteins for the treatment of vascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Alteration in apolipoprotein A-I 22-mer repeat order results in a decrease in lecithin:cholesterol acyltransferase reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Single repeat deletion in ApoA-I blocks cholesterol esterification and results in rapid catabolism of delta6 and wild-type ApoA-I in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Identification of a sequence of apolipoprotein A-I associated with the activation of Lecithin:Cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Isolation and characterization of human apolipoprotein A-I Fukuoka (110 Glu----Lys). A novel apolipoprotein variant

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Inherited predisposition to generalized amyloidosis. Clinical and pathological study of a family with neuropathy, nephropathy, and peptic ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based survey

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2801%2900163-3

7 January 2021

10.1016/S1050-1738(01)00163-3

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12007737